Terex Corporation (TEX)
NYSE: TEX · Real-Time Price · USD
48.59
+0.11 (0.23%)
Aug 8, 2025, 4:00 PM - Market closed

Inozyme Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
374388371304.1266.9665
Upgrade
Cash & Short-Term Investments
374388371304.1266.9665
Upgrade
Cash Growth
17.13%4.58%22.00%13.94%-59.87%24.28%
Upgrade
Accounts Receivable
904643548547.5507.7381.2
Upgrade
Other Receivables
-271114.752.456.2
Upgrade
Receivables
904670559562.2560.1437.4
Upgrade
Inventory
1,2551,1471,186988.4813.5610.4
Upgrade
Prepaid Expenses
152109125105.3122.4158.6
Upgrade
Other Current Assets
-16424.97.2
Upgrade
Total Current Assets
2,6842,3202,2451,9621,7681,879
Upgrade
Property, Plant & Equipment
742850696555528.8509.5
Upgrade
Goodwill
1,1021,093295284.4280.1275.4
Upgrade
Other Intangible Assets
1,0681,1071617.413.48.3
Upgrade
Long-Term Deferred Charges
-4589.51215.4
Upgrade
Other Long-Term Assets
556315355289.8261.4344.6
Upgrade
Total Assets
6,1525,7303,6153,1182,8643,032
Upgrade
Accounts Payable
766580703624.6537.7369.9
Upgrade
Accrued Expenses
120120138106.3111.689
Upgrade
Current Portion of Long-Term Debt
10431.95.68.8
Upgrade
Current Portion of Leases
-312826.320.224.8
Upgrade
Current Unearned Revenue
17205---
Upgrade
Other Current Liabilities
380318242239.5234.8230.8
Upgrade
Total Current Liabilities
1,2931,0731,119998.6909.9723.3
Upgrade
Long-Term Debt
2,5832,568611769.46651,164
Upgrade
Long-Term Leases
-1151016776.687.3
Upgrade
Long-Term Unearned Revenue
19164---
Upgrade
Other Long-Term Liabilities
292866355.846.262.6
Upgrade
Total Liabilities
4,1873,8981,9431,9371,7542,110
Upgrade
Common Stock
1110.90.90.9
Upgrade
Additional Paid-In Capital
927921906881.6860837.9
Upgrade
Retained Earnings
2,0351,9641,6751,201936.9750.3
Upgrade
Treasury Stock
-722-672-623-560.3-459.7-459.2
Upgrade
Comprehensive Income & Other
-276-382-287-341.6-228.5-208.4
Upgrade
Total Common Equity
1,9651,8321,6721,1811,110921.5
Upgrade
Shareholders' Equity
1,9651,8321,6721,1811,110921.5
Upgrade
Total Liabilities & Equity
6,1525,7303,6153,1182,8643,032
Upgrade
Total Debt
2,5932,718743864.6767.41,285
Upgrade
Net Cash (Debt)
-2,219-2,330-372-560.5-500.5-620.3
Upgrade
Net Cash Per Share
-33.14-34.47-5.45-8.08-7.06-8.85
Upgrade
Filing Date Shares Outstanding
65.666.46767.569.769.4
Upgrade
Total Common Shares Outstanding
64.965.766.166.869.268.6
Upgrade
Working Capital
1,3911,2471,126963.4857.91,155
Upgrade
Book Value Per Share
30.2827.8825.3017.6816.0313.43
Upgrade
Tangible Book Value
-205-3681,361879.4816.1637.8
Upgrade
Tangible Book Value Per Share
-3.16-5.6020.5913.1611.799.30
Upgrade
Machinery
994935794665.7686.8640.3
Upgrade
Construction In Progress
1121117492.926.931.1
Upgrade
Leasehold Improvements
63605249.95049.9
Upgrade
Order Backlog
-2,2913,411---
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q